Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Journal of Medicinal Chemistry|August 16, 2011
Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26)Mohamed S Gomaa, Caroline E Bridgens, Gareth J Veal, et al.Journal of Medicinal Chemistry|August 23, 2014
Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluationSalvatore Ferla, Ahmed S Aboraia, Andrea Brancale, et al.RSC Medicinal Chemistry|February 6, 2025
Development of benzofuran-derived sulfamates as dual aromatase-steroid sulfatase inhibitors (DASIs): design, synthesis and biological evaluationAhmed G Eissa, Francesca Gozzi, Oqab Aloqab, et al.Archiv Der Pharmazie|June 6, 2023
Targeting Mycobacterium tuberculosis: Synthesis, in vitro and in silico evaluation of novel NAmira G Zawal, Marwa M Abdel-Aziz, Abdalla A El-Shanawani, et al.Journal of Medicinal Chemistry|March 25, 2011
Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoatesMohamed S Gomaa, Caroline E Bridgens, Ahmed S Aboraia, et al.Bioorganic & Medicinal Chemistry|June 26, 2012
Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffoldMohamed S Gomaa, Caroline E Bridgens, Nicola A Illingworth, et al.Molecules (Basel, Switzerland)|November 3, 2020
Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking StudiesSafaa M Kishk, Rania M Kishk, Asmaa S A Yassen, et al.Scientific Reports|January 12, 2021
Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosisAmit Kumar, Christopher S Campomizzi, Natalie Jay, et al.Plos Medicine|December 16, 2020
Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health dataIryna Schlackow, Claire Simons, Jason Oke, et al.Bioorganic & Medicinal Chemistry|July 3, 2010
Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamidesAhmed S Aboraia, Sook Wah Yee, Mohamed Sayed Gomaa, et al.Pageof 7